Omni Health, Inc. (OMHE)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Omni Health, Inc. (OMHE) with AI Score 63/100 (Hold). Omni Health, Inc. operates a pharmacy and distributes health and wellness products, including anti-aging cream. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 17, 2026Omni Health, Inc. (OMHE) Healthcare & Pipeline Overview
Omni Health, Inc. focuses on health, wellness, and pharmacy services, operating through its Malecon Pharmacy subsidiary in Florida. The company manufactures and distributes anti-aging cream, positioning itself within the competitive medical and pharmaceutical sector with a focus on niche product offerings.
Investment Thesis
Omni Health, Inc. presents a focused business model centered on pharmacy services and the distribution of anti-aging cream. With a P/E ratio of 0.02 and a profit margin of 27.0%, the company demonstrates potential profitability. Growth catalysts include expanding its product line and geographic reach. However, the company's small market capitalization and OTC listing introduce liquidity and regulatory risks. The investment thesis hinges on Omni Health's ability to scale its operations and capitalize on the growing demand for health and wellness products. Key value drivers include increasing sales of anti-aging cream and expanding the pharmacy's service offerings. The absence of dividend yield may deter some investors, but the company's growth potential could offer attractive returns.
Based on FMP financials and quantitative analysis
Key Highlights
- P/E ratio of 0.02 indicates potential undervaluation relative to earnings.
- Profit margin of 27.0% suggests efficient cost management and strong pricing power.
- Gross margin of 33.1% reflects the profitability of the company's products and services.
- Market capitalization of $0.00B indicates that it is a micro-cap entity.
- The company operates through its subsidiary, Malecon Pharmacy, Inc., in Hialeah, Florida.
Competitors & Peers
Strengths
- Local market knowledge in Hialeah, Florida.
- Proprietary anti-aging cream product.
- Established pharmacy operations.
- Profit Margin of 27.0%
Weaknesses
- Limited geographic reach.
- Dependence on a single pharmacy location.
- Small market capitalization.
- OTC listing introduces liquidity and regulatory risks.
Catalysts
- Potential expansion of product line to include new health and wellness products within the next 2-3 years.
- Possible launch of an e-commerce platform within the next year to expand geographic reach.
- Continued operation of Malecon Pharmacy, Inc. in Hialeah, Florida, providing a stable revenue stream.
- Manufacturing and distribution of anti-aging cream, catering to a specific market segment.
- Strategic partnerships with local healthcare providers within the next year.
Risks
- Limited liquidity due to OTC Other listing, making it difficult to buy or sell shares.
- Lack of stringent financial reporting requirements, increasing the risk of fraud or manipulation.
- Competition from larger pharmacy chains and online retailers.
- Changing regulations in the pharmaceutical industry.
- Economic downturn affecting consumer spending on health and wellness products.
Growth Opportunities
- Expanding Product Line: Omni Health can expand its product line beyond anti-aging cream to include other health and wellness products. The global market for dietary supplements and vitamins is projected to reach $230.73 billion by 2027, presenting a significant opportunity for Omni Health to diversify its revenue streams. Timeline: Within the next 2-3 years, Omni Health could introduce new products through strategic partnerships or internal development, leveraging its existing distribution channels and customer base.
- Geographic Expansion: Omni Health can expand its geographic reach beyond Hialeah, Florida, by opening additional pharmacy locations or establishing online sales channels. The e-pharmacy market is growing rapidly, with a projected value of $177.79 billion by 2026, offering a scalable and cost-effective way to reach new customers. Timeline: Omni Health could launch an e-commerce platform within the next year and explore opportunities to open new pharmacy locations in underserved areas within the next 3-5 years.
- Strategic Partnerships: Omni Health can form strategic partnerships with other healthcare providers, such as doctors' offices and clinics, to offer its products and services to a wider audience. Collaborative care models are becoming increasingly popular, creating opportunities for pharmacies to integrate into the broader healthcare ecosystem. Timeline: Omni Health could establish partnerships with local healthcare providers within the next year, offering bundled services and cross-promotional opportunities.
- Manufacturing Capabilities: Omni Health can leverage its manufacturing capabilities to develop and market new anti-aging products. The global anti-aging market is projected to reach $83.2 billion by 2027, driven by increasing demand for innovative skincare solutions. Timeline: Omni Health could invest in research and development to create new anti-aging formulations within the next 2-3 years, targeting specific skin concerns and demographic groups.
- Telehealth Services: Omni Health can integrate telehealth services into its pharmacy operations, offering remote consultations and prescription refills. The telehealth market is experiencing rapid growth, with a projected value of $55.6 billion by 2027, driven by increasing demand for convenient and accessible healthcare solutions. Timeline: Omni Health could launch a telehealth platform within the next year, offering virtual consultations and prescription management services to its customers.
Opportunities
- Expanding product line to include other health and wellness products.
- Geographic expansion through online sales channels.
- Strategic partnerships with other healthcare providers.
- Leveraging manufacturing capabilities to develop new anti-aging products.
Threats
- Competition from larger pharmacy chains and online retailers.
- Changing regulations in the pharmaceutical industry.
- Economic downturn affecting consumer spending on health and wellness products.
- Potential product liability claims related to anti-aging cream.
Competitive Advantages
- Local Presence: Established presence in Hialeah, Florida, providing convenient access to pharmacy services for local residents.
- Proprietary Product: Manufacturing and distribution of its own anti-aging cream, offering a unique product to customers.
- Customer Relationships: Building relationships with local customers through personalized service and health advice.
About OMHE
Omni Health, Inc., through its subsidiary Malecon Pharmacy, Inc., provides health, wellness, and pharmacy services in Hialeah, Florida. The company also manufactures, sells, and distributes anti-aging cream. Omni Health is a subsidiary of LX Retail Group, Inc. The company's origins and evolution are not detailed in the provided information, but its current operations center around providing pharmaceutical services and distributing health and wellness products, with a specific focus on anti-aging solutions. Malecon Pharmacy serves as the primary operational arm, delivering direct services to customers in the Hialeah region. The company's competitive positioning within the broader healthcare and pharmaceutical market is not explicitly defined, but its niche focus on anti-aging cream suggests a targeted approach to specific consumer needs. Omni Health's reliance on a single pharmacy location and a limited product range may present both opportunities and challenges in terms of scalability and market reach. Further details on the company's historical performance, strategic initiatives, and expansion plans are needed to fully assess its long-term prospects. The company's financial performance, including its market capitalization of $0.00B, indicates that it is a micro-cap entity.
What They Do
- Operates a pharmacy in Hialeah, Florida through its subsidiary, Malecon Pharmacy, Inc.
- Provides health, wellness, and pharmacy services to the local community.
- Manufactures, sells, and distributes anti-aging cream.
- Offers prescription filling and medication counseling services.
- Sells over-the-counter medications and health products.
- Provides health and wellness advice to customers.
Business Model
- Generates revenue through the sale of prescription medications and over-the-counter health products.
- Earns revenue from the manufacture and distribution of anti-aging cream.
- Provides pharmacy services, including prescription filling and medication counseling.
Industry Context
Omni Health, Inc. operates within the medical and pharmaceutical sector, which is characterized by continuous innovation and evolving regulatory landscapes. The market for health, wellness, and anti-aging products is experiencing growth, driven by an aging population and increasing health consciousness. The competitive landscape includes established pharmaceutical companies, retail pharmacies, and specialized skincare brands. Omni Health's focus on a specific geographic area and niche product (anti-aging cream) differentiates it from larger competitors. The company's success depends on its ability to effectively market its products and services, comply with regulatory requirements, and adapt to changing consumer preferences.
Key Customers
- Individuals seeking prescription medications and over-the-counter health products in Hialeah, Florida.
- Customers interested in anti-aging solutions and skincare products.
- Local residents seeking pharmacy services and health advice.
Financials
Chart & Info
Omni Health, Inc. (OMHE) stock price: Price data unavailable
Latest News
-
Stocks That Hit 52-Week Lows On Tuesday
· Mar 24, 2020
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OMHE.
Price Targets
Wall Street price target analysis for OMHE.
MoonshotScore
What does this score mean?
The MoonshotScore rates OMHE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andrey Soloviev
CEO
Andrey Soloviev serves as the CEO of Omni Health, Inc. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data. Further research would be required to provide a comprehensive profile of his professional experience and qualifications.
Track Record: Due to the limited information available, a detailed assessment of Andrey Soloviev's track record and key achievements as CEO of Omni Health, Inc. cannot be provided. His tenure and significant milestones under his leadership are currently unknown.
OMHE OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Omni Health, Inc. may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and regulatory oversight compared to those listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility due to the lack of stringent listing requirements and readily available information.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to OTC Other listing.
- Lack of stringent financial reporting requirements.
- Potential for price volatility due to low trading volume.
- Higher risk of fraud or manipulation compared to listed exchanges.
- Limited regulatory oversight and investor protection.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Determine the company's ownership structure and any potential conflicts of interest.
- Analyze the company's capital structure and debt levels.
- Consult with a qualified financial advisor before investing.
- Operation of a physical pharmacy location in Hialeah, Florida.
- Manufacturing and distribution of its own anti-aging cream.
- Positive profit margin of 27.0%.
- Subsidiary of LX Retail Group, Inc.
- P/E ratio of 0.02
Omni Health, Inc. Healthcare Stock: Key Questions Answered
What does Omni Health, Inc. do?
Omni Health, Inc., through its subsidiary Malecon Pharmacy, Inc., operates a pharmacy in Hialeah, Florida, providing health, wellness, and pharmacy services. The company also manufactures, sells, and distributes anti-aging cream. This dual approach allows Omni Health to serve local customers directly through its pharmacy and reach a broader market with its proprietary skincare product. The company's focus on both traditional pharmacy services and specialized product offerings positions it as a niche player within the healthcare and pharmaceutical sector.
What are the main revenue streams for Omni Health, Inc.?
Omni Health, Inc. generates revenue primarily through two main streams: pharmacy services and the sale of anti-aging cream. The pharmacy services include dispensing prescription medications, selling over-the-counter drugs, and providing health and wellness advice. The sale of anti-aging cream contributes to revenue through manufacturing, distribution, and direct sales to consumers. The relative contribution of each revenue stream is not specified, but both are essential to the company's overall financial performance. Further diversification of revenue streams could mitigate risks associated with reliance on a limited number of products and services.
What are the main risks for OMHE?
Omni Health, Inc. faces several risks, including limited liquidity due to its OTC Other listing, which can make it difficult to trade shares. The lack of stringent financial reporting requirements increases the potential for fraud or manipulation. Competition from larger pharmacy chains and online retailers poses a threat to market share. Changing regulations in the pharmaceutical industry could impact compliance costs and operational efficiency. An economic downturn could reduce consumer spending on health and wellness products, affecting revenue. These risks should be carefully considered before investing in OMHE.
What are the key factors to evaluate for OMHE?
Omni Health, Inc. (OMHE) currently holds an AI score of 63/100, indicating moderate score. Key strength: Local market knowledge in Hialeah, Florida. Primary risk to monitor: Limited liquidity due to OTC Other listing, making it difficult to buy or sell shares. This is not financial advice.
How frequently does OMHE data refresh on this page?
OMHE prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven OMHE's recent stock price performance?
Recent price movement in Omni Health, Inc. (OMHE) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Local market knowledge in Hialeah, Florida. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider OMHE overvalued or undervalued right now?
Determining whether Omni Health, Inc. (OMHE) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying OMHE?
Before investing in Omni Health, Inc. (OMHE), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on the company's history, management team, and financial performance.
- OTC Other listing indicates higher risk and potential for volatility.
- Disclosure status is unknown, requiring further due diligence.